BSG and hepatocellular carcinoma: More recently, Zhu et al. suppose through investigating CD147 in hepatocellular carcinoma that more CD147 expression might arouse the response of inflammatory cytokines and T cells to improve the immune environment to delay the progression of hepatocellular carcinoma [86], similar to the possible roles of CD147 in sepsis.